Q&A With Lee Helman, MD, on New Cancer Targets and Therapeutics
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Category: Research
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
According to a new report in Cancer Epidemiology, Biomarkers & Prevention, the levels of several toxic substances are elevated...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
A new study shows big data can be exploited to develop effective breast cancer prevention strategies and the NIH...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...
A nine-valent HPV vaccine currently under FDA review may prevent nearly 90 percent of cervical cancers worldwide, but we...
If you are someone who would bet all your chips on helping people not get cancer in the first...
Guest Post By Fadlo R. Khuri, MD Winship Cancer Institute of Emory University
Last week, more than 100 patients, survivors, family members, advocates, and researchers came together for a symposium at the...